NASDAQ : TMCI
Treace Medical Concepts, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 5.06 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 329.07M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 288.10M |
| Enterprise Value | 315.53M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 65.03M |
| Shares Outstanding | 65.03M |
| Shares Change (YoY) | +2.71% |
| Shares Change (QoQ) | +0.71% |
| Owned by Insiders (%) | 26.44% |
| Owned by Institutions (%) | 39.40% |
| Float | 47.84M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.40 |
| Forward PS | 1.34 |
| PB Ratio | 4.25 |
| P/TBV Ratio | 5.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.90 |
| Quick Ratio | 1.80 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.23 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -71.99% |
| Return on Assets (ROA) | -17.33% |
| Return on Invested Capital (ROIC) | -21.77% |
| Return on Capital Employed (ROCE) | -38.49% |
| Weighted Average Cost of Capital (WACC) | 11.19% |
| Revenue Per Employee | $456,238 |
| Profits Per Employee | -$132,258 |
| Employee Count | 450 |
| Asset Turnover | 1.06 |
| Inventory Turnover | 1.03 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.49 |
| 52-Week Price Change | -32.37% |
| 50-Day Moving Average | 4.43 |
| 200-Day Moving Average | 3.24 |
| Relative Strength Index (RSI) | 51.61 |
| Average Volume (20 Days) | 226,626 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.92M |
| Short Previous Month | 1.98M |
| Short % of Shares Out | 2.96% |
| Short % of Float | 4.02% |
| Short Ratio (days to cover) | 8.36 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 205.31M |
| Gross Profit | 163.12M |
| Operating Income | -53.72M |
| Pretax Income | -59.52M |
| Net Income | -59.52M |
| EBITDA | -46.35M |
| EBIT | -53.72M |
| Loss Per Share | -$0.93 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 45.62M |
| Total Debt | 73.05M |
| Net Cash | -27.43M |
| Net Cash Per Share | -$0.42 |
| Equity (Book Value) | 67.74M |
| Book Value Per Share | 1.04 |
| Working Capital | 78.96M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -14.58M |
| Capital Expenditures | -10.47M |
| Depreciation & Amortization | 7.37M |
| Net Borrowing | 3.00M |
| Free Cash Flow | -25.05M |
| FCF Per Share | -$0.39 |
Margins
| Measure | Value |
|---|
| Gross Margin | 79.45% |
| Operating Margin | -26.17% |
| Pretax Margin | -28.99% |
| Profit Margin | -28.99% |
| EBITDA Margin | -22.58% |
| EBIT Margin | -26.17% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.71% |
| Shareholder Yield | -2.71% |
| Earnings Yield | -20.91% |
| FCF Yield | -8.69% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.50 |
| Price Target Difference | 24.15% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 3.61% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.18 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |